Influenza and Pneumococcal Vaccine Quick Reference Guide ...



Seasonal Influenza Vaccine Quick Reference Guide 2019-2020

The quadrivalent influenza vaccines (IIV4) for 2019-20 contain the following strains:

| |A/Kansas/14/2017 (H3N2)-like virus | |B/Phuket/3073/2013-like virus |

|A/Brisbane/02/2018 (H1N1)pdm09-like virus | |B/Colorado/06/2017-like virus |(B/Yamagata/16/88 lineage) |

| | |(B/Victoria/2/87 lineage) | |

Publicly funded seasonal influenza vaccines available in Manitoba:

| |Fluzone® Quadrivalent | | |

|Product Name/ Manufacturer |Sanofi Pasteur |Flulaval® Tetra |Afluria Tetra |

| | |GlaxoSmithKline |(Seqirus) |

|Manitoba Eligibility | | | |

|Criteria | | | |

| | | | |

| | | | |

| |Universal |Universal |5 years and older |

|Vaccine preparations | | | |

| |IIV4-SD |IIV4-SD |QIIV4-SD |

| |(Inactivated influenza vaccine |(Inactivated influenza vaccine |(Inactivated influenza vaccine quadravalent-standard |

| |quadravalent-standard dose) |quadravalent-standard dose) |dose) |

|Route of Administration |IM |IM |IM |

|Authorized age for use |≥ 6 months |≥ 6 months |≥ 5 years |

|Clinically relevant |Egg Protein |Egg protein |Calcium chloride |

|non-medicinal ingredients |Formaldehyde |(- tocopheryl hydrogen succinate |Dibasic sodium phosphate (anhydrous) |

| |Triton x-100 |Polysorbate 80 |Monobasic potassium phosphate |

| |Sucrose |Formaldehyde |Monobasic sodium phosphate |

| | |Ethanol |Potassium chloride -Sodium chloride |

| | |Sodium deoxycholate | |

| | |Sucrose | |

|Thimerosal |Yes -multi-dose vial | | |

| | |Yes |Yes- multi dose vial |

| | | | |

| |No -single dose pre-filled syringe | |No -single dose pre-filled syringe |

|Antibiotics |No |No |Neomycin and polymixin B |

|Latex |No | |No |

| | |No | |

|Format available | |5 ml multi-dose vials | |

| |5 ml multi-dose vial | |5 ml multi-dose vial |

| |Single dose pre-filled syringe | |Single dose pre-filled syringe |

|Post puncture shelf life for|Until expiry date | |28 days for multi-dose vials |

|multi-dose vial | |28 days | |

|Use in pregnancy |Recommended |Recommended |Recommended |

|Storage |Store in a refrigerator |Store in a refrigerator |Store in a refrigerator |

| |(2°C – 8°C) |(2°C – 8°C) |(2°C – 8°C) |

| |DO NOT FREEZE |DO NOT FREEZE |DO NOT FREEZE |

| |Protect from light |Protect from light. |Protect from light |

Dosage:

|Age Group |IIV4-SD |Number of doses required |

| |Dose |Route/Site |Recommended Needle Gauge and |

| | | |Length* |

|6 ≤ 12 months |0.5 ml |IM | |1 or 2** |

| | |Vastus lateralis | | |

| | | |22-25 gauge | |

| | | |7/8”(2.2 cm) - 1”(2.5 cm) long | |

|>12-23 months | | | |1 or 2** |

| | |IM | | |

| | |Deltoid | | |

|2-8 years | | | |1 or 2** |

|9-17 years | | |22-25 gauge |1 |

| | | |1”(2.5 cm) - 1 ½” (3.8 cm) long | |

|18-59 years | | | |1 |

|60-64 years | | | |1 |

|≥ 65 years | | | |1 |

For IM injections, the needle must be long enough to reach muscle but not involve underlying nerves, blood vessels, or bone; insert the needle as far as possible into the muscle.

** Children 6 months to less than 9 years of age who have never received the seasonal influenza vaccine require two doses of influenza vaccine, with a minimum interval of four weeks between doses. Eligible children ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download